Atlas Trials

Terlipressin Infusion in Variceal Hemorrhage

Clinical trial NCT04028505 · UNKNOWN

Trial details

NCT number
NCT04028505
Sponsor
Aga Khan University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Terlipressin Adverse Reaction
Start date
2018-10-25
Primary completion
2020-04-25
Enrollment
128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.